• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Lung cancer patients may benefit from delayed chemotherapy after surgery

Bioengineer by Bioengineer
January 5, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New Haven, Conn.– A new Yale study suggests that patients with a common form of lung cancer may still benefit from delayed chemotherapy started up to four months after surgery, according to the researchers.

The study was published online by JAMA Oncology on Jan. 5, 2017.

Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined. For patients with non-small-cell lung cancer (NSCLC) — one of two major types of lung cancer — chemotherapy after cancer surgery has been shown to benefit patients with larger tumors or those with cancer in the lymph nodes.

While there is consensus regarding the use of chemotherapy after cancer surgery, the optimal timing is poorly defined. Many clinicians support starting chemotherapy within six to nine weeks after surgery. But factors such as postoperative complications may affect a patient's ability to tolerate chemotherapy following surgery.

For the study, associate professor of surgery Daniel J. Boffa, M.D., and coauthors used data from patients in the National Cancer Database to examine the relationship between the timing of postoperative chemotherapy and five-year mortality.

The study of 12,473 patients with stage I, II, or III disease who received chemotherapy suggests that the initiation of chemotherapy between 57 and 127 days postoperatively led to similar outcomes as patients who started closer to the currently recommended six-to-nine-week window, report the researchers. Furthermore, delayed chemotherapy was associated with a lower risk of death compared to those patients treated only with surgery.

While the study results did not establish causality, they suggest a benefit of delayed chemotherapy for NSCLC patients, said Boffa. "Patients treated surgically for NSCLC continue to benefit from chemotherapy when given outside the traditional postoperative window.

"Clinicians should still consider chemotherapy in appropriately selected patients who are healthy enough to tolerate it, up to four months after NSCLC surgical resection," he said. "Further study is warranted to confirm these findings." Boffa is a member of Yale Cancer Center and clinical program leader of the Thoracic Oncology Program at Smilow Cancer Hospital.

###

Other Yale authors include Michelle C. Salazar, Joshua Rosen, Zuoheng Wang, Brian Arnold, Daniel Thomas, Roy Herbst, Anthony Kim, Frank Detterbeck, and Justin Blasberg.

The research was supported by contributions from Boffa's patients and their friends and family members.

Citation: JAMA Oncology

Media Contact

Ziba Kashef
[email protected]
203-436-9317
@yale

http://www.yale.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Genetic Influences Shape Kids’ Brain and Behavior

September 26, 2025

Closing the Discharge Quality Gap: Five Key Strategies

September 26, 2025

Zuogui Pill’s Mechanism in PCOS Revealed by Proteomics

September 26, 2025

Innovative Energy-Saving Technique Transforms Water Pollutants into Valuable Ammonia

September 26, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    79 shares
    Share 32 Tweet 20
  • Physicists Develop Visible Time Crystal for the First Time

    72 shares
    Share 29 Tweet 18
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    55 shares
    Share 22 Tweet 14
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Genetic Influences Shape Kids’ Brain and Behavior

Closing the Discharge Quality Gap: Five Key Strategies

Zuogui Pill’s Mechanism in PCOS Revealed by Proteomics

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.